RxDoctor Payments Data

Thomas Thorsen, DO

Interventional Pain Medicine · Mequon, WINPI 1205299146

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.9% of the total across 28 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 6 manufacturers reported payments, led by Medtronic at 56.0% of the total. 2025 is the largest year on record at $1,223, 2.7 times the $454 reported in 2021. That places this record below the midpoint for interventional pain medicine clinicians in WI, where the typical reported total is $2,684.

$2,684in general payments, 2019–2025

Across 28 payments — averaging $95.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$2K
  • SPR Therapeutics, Inc$415
  • Nevro Corp.$332
  • Abbott$203
  • Boston Scientific$200
  • Pacira Pharmaceuticals Incorporated$31

What the payments were for

  • Travel & lodging$40%
  • Food & beverage$2,680100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,684 in reported general payments places this provider in the 50th percentile of 41 interventional pain medicine providers in Wisconsin.

See all interventional pain medicine providers in Wisconsin

Medicare billing

Part B allowed, 2024
$108,931
Medicare patients
237
Services billed
1,744

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin282$4,297
Pregabalin82$2,497
Tizanidine Hcl77$1,393
Lidocaine18$1,215
Diclofenac Sodium27$965
Duloxetine Hcl40$852
Cyclobenzaprine Hcl49$734
Baclofen22$654
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen22$264
Tramadol Hcl45$197
Acetaminophen-CodeineAcetaminophen With Codeine20$176
Meloxicam32$79

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Mequon

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →